| Name | Title | Contact Details |
|---|
HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer. The Company may also explore acquiring or licensing innovative therapeutics addressing unmet needs and orphan indications beyond cancer. We are focused on the development of therapies for more than one type of cancer, with initial emphasis in the U.S. market, based upon repurposing the currently marketed antifungal drug itraconazole for new indications in oncology.
BayStar EMS is a Baytown, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
When Ginger co-founder and COO, Karan Singh, was young, his mother would brew him ginger tea when she could sense that he was about to get sick. A preventative health remedy that originates from Southeast Asia, the ginger root is commonly used at the first sign of illness, before things get worse. Similar to this approach, the Ginger system takes a preventative approach to mental health, addressing issues before they evolve into greater challenges and providing support anywhere, at any time. By bringing the power of on-demand mental health support to hundreds of thousands of people globally, we continue to advance our mission of creating a world where mental health is never an obstacle.
Kite Pharma, founded in 2009, is dedicated to the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to fight tumor cells. Kite’s lead programs are in collaboration with the National Cancer Institute (NCI) and are being studied through the NCI’s Surgery Branch led by Steven A. Rosenberg, MD, PhD, who has pioneered immunotherapy approaches for cancer for more than two decades. This research has resulted in breakthrough clinical findings, including results from an NCI Phase 1/2a trial being presented at this year’s American Society of Hematology (ASH) Annual Meeting. Based on this progress and momentum, Kite plans to initiate a company-sponsored multicenter clinical program in aggressive non-Hodgkin’s lymphoma, with additional filings expected for other eACT™ products in diverse oncology indications.
The California Poison Control System (CPCS) is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.